Etoposide loaded solid lipid nanoparticles for curtailing B16F10 melanoma colonization in lung

Biomedicine and Pharmacotherapy

Volumn 68, Issue 2, 2014, Pages 231-240

  Athawale, Rajani B ^a   Jain, Darshana S ^a   Singh, Kamlinder K ^a   Gude, Rajiv P ^b  

^a SNDT WOMEN S UNIVERSITY   (India)

^b TATA MEMORIAL HOSPITAL   (India)

Author keywords

B16F10 melanoma model; Etoposide; Metastasis; Solid lipid nanoparticles (SLN)

Indexed keywords

ETOPOSIDE; SOLID LIPID NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG SOLUBILITY; FEMALE; HEMOLYMPHATIC SYSTEM; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; MELANOMA; METASTASIS INHIBITION; MOUSE; MTT ASSAY; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SURVIVAL RATE; SUSTAINED RELEASE FORMULATION; THERMOGRAPHY;

B16F10 MELANOMA MODEL; ETOPOSIDE; METASTASIS; SOLID LIPID NANOPARTICLES (SLN);

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL SURVIVAL; DRUG CARRIERS; DRUG COMPOUNDING; ETOPOSIDE; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; SOLUBILITY; SURFACE PROPERTIES; SURVIVAL ANALYSIS; TISSUE DISTRIBUTION; TRIGLYCERIDES;

EID: 84897071105     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2014.01.004     Document Type: Article

References (16)

1. Harrap K.R., Davis W., Calvert A.H., Issell B. Current clinical progress podophyllotoxins. Cancer chemotherapy and selective drug development 1984, 65-69. Springer, US.
2. Steward W.P., Thatcher N., Edmundson J.M., Shiu W., Wilkinson P.M. Etoposide infusions for treatment of metastatic lung cancer. Cancer Treat Rep 1984, 68:897-899.
3. Baldwin E.L., Osheroff N. Etoposide, topoisomerase II and cancer. Curr Med Chem Anticancer Agents 2005, 5:363-372.
4. Strickley R.G. Solubilizing excipients in oral and injectable formulations. Pharm Res 2004, 21:201-230.
5. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007, 2(12.).
6. Greish K. Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. Methods Mol Biol 2010, 624:25-37.
7. Pawar K.R., Babu R.J. Polymeric and lipid-based materials for topical nanoparticle delivery systems. Crit Rev Ther Drug Carrier Syst 2010, 27:419-459.
8. Mehnert W., Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 2001, 47:165-196.
9. Masquelier M.L., Vitols S., Peterson C. Low-density lipoprotein as a carrier of antitumoral drugs: in vivo fate of drug-human low-density lipoprotein complexes in mice. Cancer Res 1986, 46:3842-3847.
10. Callewaert M., Dukic S., Van Gulick L., Vittier M., Gafa V., Andry M.C., et al. Etoposide encapsulation in surface-modified poly(lactide-co-glycolide) nanoparticles strongly enhances glioma antitumor efficiency. J Biomed Mater Res A 2012, 101:1319-1327.
11. Yadav K.S., Sawant K.K. Formulation optimization of etoposide loaded PLGA nanoparticles by double factorial design and their evaluation. Curr Drug Deliv 2010, 7:51-64.
12. Snehalatha M., Venugopal K., Saha R.N., Babbar A.K., Sharma R.K. Etoposide loaded PLGA and PCL nanoparticles II: biodistribution and pharmacokinetics after radiolabeling with Tc-99m. Drug Deliv 2008, 15:277-287.
13. Yadav R., Kumar D., Kumari A., Yadav S.K. Encapsulation of podophyllotoxin and etoposide in biodegradable poly-d,l-lactide nanoparticles improved their anticancer activity. J Microencapsul 2013, 10.3109/02652048.2013.834988.
14. Jain D., Athawale R., Bajaj A., Shrikhande S., Goel P.N., Gude R.P. Studies on stabilization mechanism and stealth effect of poloxamer 188 onto PLGA nanoparticles. Colloids Surf B Biointerfaces 2013, 109:59-67.
15. Nerkar N., Bajaj A., Shrikhande S., Jain D. Fabrication of lipospheres for paclitaxel and assessment of in vitro cytotoxicity against U373 cancer cell lines. Thai J Pharm Sci 2013, 36:117-130.
16. Jain D.S., Athawale R.B., Bajaj A.N., Shrikhande S.S., Goel P.N., Nikam Y., et al. Poly lactic acid (PLA) nanoparticles sustain the cytotoxic action of temozolomide in C6 Glioma cells. Biomed Aging Pathol 2013, 3(4):201-208.